Curia’s Health, Care, and Life Sciences Research Group has submitted their implementation plan for how a new government can implement their plans for a new Life Sciences Industrial Strategy. Subscribers will receive an exclusive copy of the report.
New subscribers will receive a copy of the report, alternatively a copy can be purchased at www.chamberuk.com/shop.
This article outlines a key learning from the document and a short summary of a case study.
Key Finding: Clinical Uptake, Adoption and Improved Population Outcomes
Timely access to innovative solutions for patients requires strong clinical leadership, supportive management, and clear pathways for adopting new medicines and technologies. Recognising the challenges in this area, the report proposes a fresh approach that combines centralised ‘push’ strategies with localised ‘pull’ methods to drive access and uptake effectively. This dual approach aims to ensure that innovations reach patients swiftly and are integrated into everyday clinical practice.
One of the major barriers to the adoption of new technologies in healthcare is the complexity of the healthcare system itself. Different regions and institutions may have varying capabilities and resources, making it challenging to implement a one-size-fits-all approach. The proposed combination of centralised and localised strategies addresses this issue by providing a flexible framework that can be adapted to different contexts.
Centralised ‘push’ strategies involve initiatives led by the Government or NHS to promote the adoption of new technologies. These may include national campaigns, funding programmes, and policy mandates that encourage healthcare providers to integrate innovative solutions into their practice.
Localised ‘pull’ methods, on the other hand, focus on creating demand at the grassroots level. This involves engaging with local healthcare providers, patients, and communities to build awareness and support for new technologies. By addressing the specific needs and concerns of local stakeholders, these methods can drive the adoption of innovations in a more organic and sustainable manner.
Case Study
4. C2-AI: Transforming the “Waiting List” Into a “Preparation List”
NHS Cheshire and Merseyside’s initiative uses risk stratification (C2-Ai) and digital perioperative care (Surgery Hero) to identify and support high-risk patients awaiting surgery. The process involves three stages: referring high-risk individuals for prehabilitation, assigning personal health coaches, and setting health behaviour goals to improve overall wellness. Professor Rowan Pritchard Jones highlighted the technology’s ability to enhance patient outcomes and optimise NHS resources. Tom Coalbran noted a significant reduction in independent sector rejections and improved patient streaming. This approach pre-emptively mitigates negative outcomes, alleviating press ure and allowing the NHS to reinvest resources into services.
How to Get Involved
The Curia report, developed in partnership with the LSE, and sponsors IQVIA and Genomics PLC offers a comprehensive blueprint for revitalising the UK’s life sciences sector. By focusing on clinically engaged approaches, investment and growth, regulatory frameworks, clinical uptake, and robust governance, the report provides a clear path forward for leveraging the UK’s strengths. For those in the public sector and Curia subscribers, the reader will see recommendations that aim to ensure that the UK remains at the forefront of life sciences innovation, delivering tangible benefits for patients and the economy alike.
Following the outcome of the general election, the new Government must take decisive action to harness the UK’s world-leading scientific expertise, advanced healthcare infrastructure, and pioneering AI capabilities. With the right strategic priorities and public policy measures in place, the UK can reclaim its position as a global leader in life sciences and secure a sustainable future for its healthcare system.
Implementing these recommendations will require commitment and collaboration from all stakeholders involved. That means we need your help. Over the coming months, Curia will work with the new Government to help them implement the recommendations in this report, supporting with views about best ways to operationalise their manifesto commitments. To do this we require the help of the NHS to feed in their thoughts and for the life sciences sector to highlight examples of best practice that will highlight new ways of working.
For those who will be able to read the evidence contained in the report, the case studies and the recommendations, your feedback will be incredibly helpful – not just for the Health, Care, and Life Sciences Advisory Board, but also for new Ministers as they navigate their implementation plans.
The challenges are significant, but so are the opportunities. By working together, the UK can create a vibrant and dynamic life sciences sector that drives innovation, improves patient outcomes, and contributes to economic growth.
This is just one of the articles that features in the Health, Care and Life Sciences section of Chamber UK’s pre-election journal. To gain full access, please subscribe here.
